tag:blogger.com,1999:blog-7923257243013351762011-04-21T21:54:04.104-07:00AdipexJerrynoreply@blogger.comBlogger11100tag:blogger.com,1999:blog-792325724301335176.post-33347579028123475142007-09-16T02:27:00.001-07:002007-09-16T02:27:24.868-07:00<div align="justify">Caraco Pharma announces FDA approval to market generic version of Adipex-P(R) Co announces that the FDA has granted final approval for the Company's Abbreviated New Drug Application for Phentermine Hydrochloride Tablets USP, 37.5 mg. Phentermine HCl is indicated only as short-term monotherapy for the management of exogenous obesity. Firm's generic Phentermine HCl is the bioequivalent to Adipex-P(R), a registered trademark of TEVA Pharmaceuticals USA, Inc. According to IMS Data, for the twelve months ended June 2007, Phentermine HCl generic and brand products (Adipex-P(R)) combined had annual sales of approximately $34 million.</div><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/792325724301335176-3334757902812347514?l=adipex07.blogspot.com' alt='' /></div>Jerrynoreply@blogger.com